草药组合"HAGE-101912"改善了老鼠的胃食道逆流病
Mohammed M Azeemuddin1, Madan M Narendra1, Onkaramurthy Mallappa1
1Research and Development, Himalaya Wellness Company, Makali, Bengaluru, Karnataka, India.
Journal of pharmacy & bioallied sciences
|January 18, 2024
概括
这项研究表明,HAGE-101912,一种草药组合,通过减少酸并保护食道,有效治疗胃食道逆流症 (GERD). 它为GERD管理提供了一个有前途的替代疗法.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 草药是一种草药.
背景情况:
- 胃食道逆流性疾病 (GERD) 由于现代生活方式,越来越普遍.
- 目前的治疗方法,如质子抑制剂 (PPI) 有局限性,需要替代疗法.
研究的目的:
- 为了评估HAGE-101912的疗效,一种草药组合,在GERD的实验模型中.
主要方法:
- 通过H+/K+ATPase抑制和下食道 (LES) 收缩评估抗酸活性.
- 使用大鼠GERD模型 (骨髓和骨髓绑定) 来评估HAGE-101912 (250毫克/公斤).
- 测量了胃的pH值,体积,酸度,食道指数和组织病理学;使用红法评估了生殖活性.
主要成果:
- HAGE-101912表现出显著的酸中和能力和H+/K+ATPase抑制 (P < 0.001,P < 0.01).
- 它增加了 LES 收缩,胃 pH 和受保护的食道上皮,同时降低了胃酸量,总酸度和指数 (P < 0.01).
- 促基因活性导致胃排空和过境的增加 (P < 0.05).
结论:
- 在GERD模型中,HAGE-101912表现出有益的效果.
- 它通过抑制H+/K+ATPase,增加胃pH,恢复LES功能,并保护食道上皮作用.
- 这种草药组合还可以增强胃排空和过境,这表明GERD具有多方面的治疗潜力.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
88
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
485
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
485
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
319
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
319
Peptic Ulcer Disease IV: Management
94
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
94


